From: Effects of DNA methylation on cardiometabolic risk factors: a systematic review and meta-analysis
First author | Country/year | Study Type | Sample size | Study Characteristic | Tissue | Gene Site | Adjusted covariates | Results | Quality assessment*2 |
---|---|---|---|---|---|---|---|---|---|
Daniel Castellano-Castillo [9] | Spain 2018 | case-control | 108 | Non MetS (55) Age:48.4 ± 13.9 BMI:29.8 ± 7.9 M/F: 52/48 MetS (53) Age:52.7 ± 14.6 BMI:36.4 ± 10.9 M/F: 44/56 | Visceral Adipose Tissue | LINE-1 P1-P6*1 | age, sex | Negative correlation between LINE-1 P2 and the MetS index and no correlation at P1, P3, P4, P5, P6. Negative correlations between LINE-1 P1, P2 and P5 and glucose levels. No correlation between LINE-1 and P3, P4, P6 and glucose levels. | 18 |
Valérie Turcot [7] | Canada 2012 | case-control | 176 | severely obese undergoing a biliopancreatic diversion with sleeve gastrectomy to treat obesity Non MetS (98) Age mean: 34.9 ± 8.1 BMI mean:49.8 ± 8.4 M/F: 14/84 MetS (88) Age mean: 35.3 ± 7.3 BMI mean:53.8 ± 10.8 M/F: 20/68 | Visceral Adipose Tissue | LINE-1 | age, sex and smoking | LINE-1%meth levels in VAT were associated negatively with fasting plasma glucose, blood pressure and MetS. | 18 |
Jose Luiz Marques-Rocha [10] | Brazil 2016 | cross-sectional | 156 | M/F:91/65 Age mean: 23.1 ± 3.5 BMI mean: 22 ± 2.9 | WBC | LINE-1 | calories, sex, age, smoking, regular physical activity | LINE-1 methylation associated with body fat, waist girth and waist-to-hip ratio, total fat mass, blood pressure. | 20 |
Mark S Pearce [8] | UK 2012 | Cohort (The Newcastle Thousand Families Study) | 228 | Age: 49–51 y BMI mean: 25.70 (22.94–28.93) M/F: 85/143 | peripheral blood samples | LINE-1 | Sex | Increased LINE-1 DNA methylation was associated with increasing fasting glucose, total cholesterol, total triglycerides, and LDL cholesterol and with decreasing HDL cholesterol, and HDL:LDL ratio | 18 |
Haley L. Cash [21] | US 2011 | case-control | 355 | American Samoa (198) Age mean: M (57): 36.1 ± 5.4 F(141):29.7 ± 6.8 BMI mean: M (57): 34.8 ± 6.6 F(141): 36.0 ± 9.2 Samoa (157) Age mean: M (31): 39.2 ± 5.7 F(126): 29.2 ± 6.2 BMI mean: M (31): 28.7 ± 5.4 F(126): 31.1 ± 5.8 | peripheral lymphocyte | LINE-1 | age, sex, BMI | Significant positive association between BMI and HDL with LINE-1 methylation Significant negative association between LDL and LINE-1 methylation | 17 |
Stacey E Alexeeff [22] | US 2013 | longitudinal study (cohort) | 798 | M/F: Age mean: 74 (55–100 y) BMI mean: 27.5 | buffy coat | LINE-1 | BMI, age, smoking, T2D, alcohol, race, IHD/MI, Neut count, season, day of week. | LINE-1 methylation Inversely associated with DBP, LINE-1 methylation association with SBP was weak. | 17 |
Yoshiki Tsuboi [13] | Japan 2018 | cross-sectional study | 420 | M/F:187/233 Age mean: 61.46 y BMI mean: 24.16 | WBC | LINE-1 | sex, age, smoking, alcohol, BMI, CRP, anti hyperlipidemic drug use | Significant positive association between LINE-1 DNA methylation and LDL/HDL ratio. Negative and weak association between LINE-1 DNA methylation and HDL. | 19 |
Carolina Ferreira Nicoletti [14] | Brazil-Spine 2016 | cross-sectional study | 45 | control group (9) normal weight individuals M/F: 0/9 Age mean: 31.7 ± 8.6 BMI mean: 22.0 ± 2.0 obese with energy restriction group (22) M/F: 0/22 Age mean: 52.6 ± 9.9 BMI mean: 38.2 ± 3.7 obese with bariatric surgery group (14) M/F: 0/14 Age mean: 35.5 ± 10.1 BMI mean: 44.6 ± 6.2 | buffy coats | LINE-1 | age and BMI | Significant association between LINE-1 methylation and serum glucose levels. | 18 |
Liliane Pfeiffer [11] | Germany 2014 | Augsburg cohort | 2747 | M/F: 1341/1406 Age mean: 61.63 y BMI mean: 27.46 | whole blood samples | ABCG1 cg06500161 SREBF1 cg11024682 | age,sex, BMI, smoking, alcohol, lipid lowering drugs, physical activity, history of MI, hypertension, HbA1c, CRP, WBC count | Opposite directions ABCG1 methylation association with HDL and triglyceride levels. Association between triglyceride levels and ABCG1, SREBF1. | 20 |
Alexis C. Frazier-Wood [23] | US 2014 | GOLDN cohort | 994 | Discovery (663) M/F: 312/351 Age mean: 48.6 ± 16.4 BMI mean: Replication (331) M/F: 165/166 Age mean: 47.7 ± 16.2 BMI mean: | CD4 + T cells | ABCG1 cg06500161 | age, sex, study site, and the first four principal components generated to estimate T-cell purity as fixed effects, and pedigree as a random effect using the lmekin function of the kinship package in R | LDL associated with ABCG1 methylation. | 18 |
Tasnim Dayeh [12] | Sweden 2016 | Botnia prospective study | 258 | non-diabetic at baseline: Controls (129) M/F:62/67 Age mean: 51.4 ± 9.1 BMI mean: 27.6 ± 3.0 Converters(129) M/F:65/64 Age mean: 52.8 ± 12.3 BMI mean: 28.8 ± 4.3 | blood | ABCG1 cg06500161 PHOSPHO1 cg02650017 | age, gender, fasting glucose, and family relation | Positive correlation between DNA methylation at the ABCG1 locus cg06500161 with BMI, HbA1c, fasting insulin, and triglyceride levels. Positive correlation between DNA methylation at the PHOSPHO1 locus cg02650017 with HDL levels. DNA methylation at the ABCG1 locus cg06500161: 9% increased risk for future T2D DNA methylation at the PHOSPHO1 locus cg02650017: 15% decreased risk for future T2D | 19 |
Eliza Walaszczyk [15] | Netherland 2017 | case–control sample Lifelines cohort | 198 | Type 2 diabetic (100) M/F: 52/48 Age mean: 62 (53–69y) BMI mean: 30.8 ± 4.7 Control individuals (98) M/F: 44/54 Age mean: 50 (46–63y) BMI mean: 25.3 ± 3.6 | whole blood | ABCG1 SREBF1 | age, sex, measured blood cell composition, plate number and position on the plate as covariates | ABCG1 methylation associated with FBS, TG and TC SREBF1 methylation associated with FBS, TG, TC and LDL | 18 |
John C Chambers [16] | London 2015 | prospective nested case-control (LOLIPOP) | 13,535 | M/F: 8175/5360 Age mean: 49.1 ± 10.9 BMI mean: 27.0 ± 4.4 | peripheral blood leucocytes | SREBF1 PHOSPHO1 ABCG1 | Age, sex | Methylation at SREBF1, PHOSPHO1, and ABCG1association with quantitative measures of total and regional body fat distribution | 18 |
Jennifer Kriebel [25] | Germany 2016 | KORA F4 Study | 1448 | non-diabetic individuals M/F: 682/766 Age mean: 59 (32-81y) BMI mean: 27.1 | whole blood | SREBF1 cg11024682 ABCG1 cg06500161 | age, sex, estimated white blood cell proportions, smoking, BMI | Significant associations between cg06500161 (ABCG1) methylation and waist circumference, triglycerides, fasting glucose, and 2-hour glucose, fasting insulin, CD8 + T cells, and monocytes Significant associations between cg09694782 (SREBF1) methylation and age, fasting insulin, and HOMA-IR. | 19 |
Kim V. E. Braun [24] | Netherland 2017 | Rotterdam Study | 1485 | Discovery (725) M/F: 336/389 Age mean: 59.9 ± 8.2 BMI mean: 27.6 ± 4.6 Replication (760) M/F: 334/426 Age mean: 67.7 ± 5.9 BMI mean: 27.8 ± 4.2 | whole blood | SREBF1 cg11024682 ABCG1 cg06500161 | age, gender, current smoking, leukocyte proportions, array number, and position on array | Association between ABCG1 methylation and HDL Association between ABCG1, and SREBF1 methylation with triglycerides | 21 |
Ping Peng [26] | China 2014 | case-control | 139 | CHD patients (85) M/F: 58/67.4 Age mean: 61.33 ± 9.22 control group (54) M/F: 31/57.4 Age mean: 56.35 ± 9.0 | peripheral blood | ABCG1 | age, gender, smoking, lipid level, hypertension, and diabetes | Significant statistical association of the promoter Hyper-methylation of the ABCG1 gene with CHD risk ABCG1 and GALNT2 gene promoter regions are positively associated with CHD both in the male group | 20 |
S. Sayols-Baixeras [27] | Spain 2016 | REGICOR and Framingham study cross-sectional | 2858 | REGICOR discovery sample (645) M/F: 316/329 Age mean: 63.2 ± 11.7 BMI mean: 26.9 ± 4.1 Framingham (2542) M/F: 1164/1378 Age mean: 66.3 ± 8.9 BMI mean: 28.2 ± 5.4 | whole peripheral blood | SREBF1 PHOSPHO1 ABCG1 | sex, age, smoking status,batch effect and estimated cell count | Positive association between SREBF2 methylation and TC, in the same direction as the association between SREBF1 and TG. Significant association between methylation levels of SREBF1 and HDL in the opposite direction to that observed with TG. Direct association between PHOSPHO1 methylation and HDLholesterol levels. | 21 |
Simon-Pierre Guay [28] | Canada 2014 | Case-controle study | 61 | severely obese non-FH (30) BMI > 40 familial hypercholesterolemia (61) M/F:61/0 | Whole blood | ADRB3 | age, waist circumference, fasting triglyceridemia | Higher ADRB3DNA methylation levels were significantly associated with lower low-density lipoprotein cholesterol levels in FH, and with a lower waist-to-hip ratio and higher blood pressure in severely obese men. | 17 |
Raquel PatrÃciaAtaÃde Lima [31] | Brazil 2019 | cross-sectional representative study | 265 | M/F: 79/186 Age mean: 40.3 ± 14.3 (20–59) BMI mean: 27.08 ± 5.88 | leukocytes | ADRB3 | – | LDL above the median had a 164% higher chance of ADRB3 hyper-methylation, whereas individuals with triglyceride values above the median had a higher chance of hyper-methylation. | 16 |
Andrée-Anne Houde [29] | Canada 2015 | Cross-sectional | 73 | men and premenopausal women (BMI > 40 kg/m2) undergoing bioliopancreatic diversion with duodenal switch to treat obesity (severely obese) M/F: 33/40 | whole blood SAT VAT | LEP | Age, sex and waist circumference | LEP DNA methylation levels in blood cells were negatively associated with body mass index (BMI). Fasting LDL levels positively correlated with DNA methylation levels at LEP-CpG11 and -CpG17 in blood and SAT and with ADIPOQ -CpGE1 and - CpGE3 DNA methylation levels in SAT and CpGE1 in VAT. Associations between LDL levels and both LEP and ADIPOQ DNA methylation levels. | 18 |
Jonathan Y Huang 2017 [30] | Israel | Sub-cohort | 589 | M/F: 0/589 Age mean:32 BMI mean: 27.08 ± 5.88 maternal pre-pregnancy BMI ≥27 kg/m2 and offspring birth weight ≤ 2500 g or ≥ 4000 g | peripheral blood (buffy coat) | LEP | ethnic origin, offspring age at blood draw, maternal characteristics (pre-pregnancy BMI, gestational weight gain, age, parity, education), paternal characteristics (education and smoking status), offspring variables (childhood overweight, education, parity, current smoking status) | ABCA1 methylation appeared to be directly related to both maternal gestational weight Gain and some markers of glucose homeostasis. LEP methylation associated with waist-to-hip ratio | 19 |